THOROLD, ON, Aug. 20 /CNW/ - Norgen Biotek Corp., an innovative Canadian
biotechnology company focusing primarily on advancing powerful tools for
nucleic acid and protein purification, today announced the expansion of its
product offering by launching three new kits for the isolation of RNA and DNA
from both the exfoliated cells and bacteria found in urine samples.
Norgen's Urine (Exfoliated Cell) RNA Purification Kit and Urine
(Exfoliated Cell) DNA Purification Kit will enable scientists to isolate total
RNA or genomic DNA from exfoliated cells that have been shed into the urine
from the urinary tract. The nucleic acids isolated using these novel kits can
be used in a number of research applications including studying biomarkers
that can be used for the diagnosis and monitoring of bladder, kidney, or other
urinary-tract cancers. These kits can be used to isolate RNA or DNA from as
little as 1 mL of urine. The purified nucleic acids are of the highest quality
and integrity, and are well suited to sensitive downstream applications such
as PCR, Real-Time PCR, RT-PCR, Northern Blotting and Southern Blotting.
The Urine Bacteria RNA Purification Kit is designed for the rapid
preparation of bacterial RNA from urine samples. This product allows for the
isolation of total RNA from all bacteria present in urine samples,
facilitating the study of the levels and types of bacteria present, as well as
the stage of bacterial pathogenesis through the use of RNA biomarkers. This
kit is ideal for the isolation of RNA from a wide range of bacteria found in
urine, including Chlamydia trachomatis and Neisseria gonorrhoeae.
These Urine (Exfoliated Cell) RNA and DNA Purification Kits and Urine
Bacteria RNA Purification Kit together with the previously-released Urine DNA
Isolation Kit, Urine Bacteria DNA Isolation Kit and Urine Protein
Concentration Kits constitute an extensive range of urine-based sample
preparation products. Such enabling products facilitate research for the
detection and monitoring of cancer markers, bacterial infections and biomarker
"We are very excited about the expansion of our urine-based sample
preparation kits. Our technology is well suited for use in diagnostic
applications, and these kits represent only the beginning of our move into
this area. We are committed to developing and offering powerful new products
aimed at sample preparation for genomics and proteomics customers" said Dr.
Haj-Ahmad, President & CEO of Norgen Biotek.
About Norgen Biotek Corp.
Norgen is an innovative, rapidly growing privately-held Canadian
biotechnology company specialized in the research, development, manufacture
and marketing of a variety of commercial products derived from its proprietary
technology. Currently, this technology is used in protein, RNA and DNA
purification, isolation, and concentration and clean-up kits. Norgen is
actively working on the adoption of this enabling technology into the
diagnostics market as well as industrial scale applications. We are actively
seeking suitable channels-to-market partners.
In February of 2007 Norgen Biotek moved into its new, custom-built
24,000 sq ft facility designed to meet all its present program requirements
(12,000 sq ft) and to accommodate future growth (12,000 sq ft). The new
state-of-the- art research and manufacturing facility is located on 3.4 acres,
with space for an additional 40,000 sq ft expansion on site. The building is
conveniently situated in the heart of Niagara (one hour from Toronto and less
than one hour from Buffalo), only 1 block from Brock University and adjacent
to Highway 406.
Additional information is available on the company's website:
For further information:
For further information: Dr. Yousef Haj-Ahmad, President & CEO, Norgen
Biotek Corp., Phone: (905) 227-8848, Fax: (905) 227-1061, Email: